CUBIST PHARMACEUTICALS, INC. for CUBIST PHARMACEUTICALS
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM)Act; Ongoing discussions surrounding next steps for protecting and promoting incentives for the development of resistant pathogens including breakpoints, andtibiotic resistance, reimbursement issues for antibiotics, President's Council of Advisors on Science and Technology (PCSAT)
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK THOMAS BATTAGLINI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.